Search

everythinglearnresearchcommunity

for

Search:↓

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Applying estradiol to skin causes local changes but not cancer.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Choose oral contraceptives with specific side effects to manage issues like acne and avoid unwanted effects.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.

Hormonal contraceptives are highly effective but require medical evaluation due to potential health risks.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Including androgens in hormone therapy may lower breast cancer risk.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.